Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,063 | -20,600 | -10,644 | -39,886 | -26,018 |
| Depreciation Amortization | 270 | 189 | 95 | 363 | 264 |
| Accounts payable and accrued liabilities | -2,088 | -2,747 | -2,469 | 2,349 | -112 |
| Other Working Capital | 2,558 | -1,610 | -1,989 | 443 | -31 |
| Other Operating Activity | 4,207 | 4,166 | 3,046 | -2,380 | -474 |
| Operating Cash Flow | $-26,116 | $-20,602 | $-11,961 | $-39,111 | $-26,371 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -90,421 | -17,825 | -22,825 | N/A | N/A |
| PPE Investments | -22 | N/A | N/A | -27 | N/A |
| Investing Cash Flow | $-90,443 | $-17,825 | $-22,825 | $-27 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 70,697 | 51 | N/A | 77,749 | 0 |
| Other Financing Activity | -996 | -247 | 0 | 38,362 | 41,429 |
| Financing Cash Flow | $69,701 | $-196 | $N/A | $116,111 | $41,429 |
| Beginning Cash Position | 87,338 | 87,338 | 87,338 | 10,365 | 10,365 |
| End Cash Position | 40,480 | 48,715 | 52,552 | 87,338 | 25,423 |
| Net Cash Flow | $-46,858 | $-38,623 | $-34,786 | $76,973 | $15,058 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,116 | -20,602 | -11,961 | -39,111 | -26,371 |
| Capital Expenditure | -22 | N/A | N/A | -27 | 0 |
| Free Cash Flow | -26,138 | -20,602 | -11,961 | -39,138 | -26,371 |